Search results for: 'tft pyrex through with prepar are labels'

15N Labeled Yeast Extract, 10 g

CN700P10
2 - 4 weeks

>90% ¹⁵N

15N, D Labeled Yeast Extract, 10 g

CDN700P10
2 - 4 weeks

• >90% ¹⁵N
• >80% D

Cell-Free Methyl Labeled Leu & Val Amino Acid mixture

CCDN073P
Stock

One kit of amino acids mixture allows the use of 2 starter CFPS kits or 1 large scale CFPS kit

15N Microcrystalline Ubiquitin

CN10063P10
3 - 6 weeks

• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹⁵N

15N Microcrystalline Ubiquitin

CN10063P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹⁵N

15N Microcrystalline Ubiquitin

CN10063P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹⁵N

15N Ubiquitin in Solution

CN10064P10
3 - 6 weeks

• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹⁵N

15N Ubiquitin in Solution

CN10064P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹⁵N

15N Ubiquitin in Solution

CN10064P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹⁵N

13C, 15N Microcrystalline Ubiquitin

CCN10063P10
3 - 6 weeks

• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Microcrystalline Ubiquitin

CCN10063P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Microcrystalline Ubiquitin

CCN10063P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Ubiquitin in Solution

CCN10064P10
3 - 6 weeks

• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C 15N Ubiquitin in Solution

CCN10064P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Ubiquitin in Solution

CCN10064P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D Microcrystalline Ubiquitin

CCND10063P10
3 - 6 weeks

• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline Ubiquitin

CCND10063P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline Ubiquitin

CCND10063P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Ubiquitin in Solution

CCND10064P10
3 - 6 weeks

• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Ubiquitin in Solution

CCND10064P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Ubiquitin in Solution

CCND10064P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

15N SH3 in Solution

CN10054P10
3 - 6 weeks

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹⁵N

15N SH3 in Solution

CN10054P20
3 - 6 weeks

• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹⁵N

15N SH3 in Solution

CN10054P5
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹⁵N

15N Microcrystalline SH3

CN10053P10
3 - 6 weeks

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹⁵N

15N Microcrystalline SH3

CN10053P20
3 - 6 weeks

• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹⁵N

15N Microcrystalline SH3

CN10053P5
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹⁵N

13C, 15N SH3 in Solution

CCN10054P10
3 - 6 weeks

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N SH3 in Solution

CCN10054P20
3 - 6 weeks

• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N SH3 in Solution

CCN10054P5
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6k Da
• Labeling: ¹³C, ¹⁵N

15N Calbindin in Solution

CN10014P5
3 - 6 weeks

• 5 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹⁵N

13C15N Microcrystalline SH3

CCN10053P10
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Microcrystalline SH3

CCN10053P20
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Microcrystalline SH3

CCN10053P5
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Calbindin in Solution

CCN10014P5
3 - 6 weeks

• 5 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D Microcrystalline SH3

CCND10053P10
3 - 6 weeks

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline SH3

CCND10053P20
3 - 6 weeks

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline SH3

CCND10053P5
3 - 6 weeks

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D SH3 in Solution

CCND10054P10
3 - 6 weeks

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D SH3 in Solution

CCND10054P20
3 - 6 weeks

• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N Calbindin in Solution

CCN10014P10
3 - 6 weeks

• 10 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N Calbindin in Solution

CCN10014P20
3 - 6 weeks

• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Calbindin in Solution

CCND10014P10
3 - 6 weeks

• 10 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Calbindin in Solution

CCND10014P20
3 - 6 weeks

• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Calbindin in Solution

CCND10014P5
3 - 6 weeks

• 5 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D

15N Calbindin in Solution

CN10014P10
3 - 6 weeks

• 10 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D

15N Calbindin in Solution

CN10014P20
3 - 6 weeks

• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D SH3 in Solution

CCND10054P5
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 k Da
• Labeling: ¹³C, ¹⁵N, D

15N MBP in Solution

CN10044P10
3 - 6 weeks

• 10 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹⁵N

15N MBP in Solution

CN10044P20
3 - 6 weeks

• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹⁵N

15N MBP in Solution

CN10044P5
3 - 6 weeks

• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹⁵N

13C, 15N MBP in Solution

CCN10044P10
3 - 6 weeks

• 10 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N

13C, 15N MBP in Solution

CCN10044P20
3 - 6 weeks

• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N

13C, 15N MBP in Solution

CCN10044P5
3 - 6 weeks

• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N

13C, 15N, D MBP in Solution

CCND10044P10
3 - 6 weeks

• 10 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D MBP in Solution

CCND10044P20
3 - 6 weeks

• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D MBP in Solution

CCND10044P5
3 - 6 weeks

• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N, D

15N GB1 in Solution

CN10034P10
3 - 6 weeks

• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹⁵N

15N GB1 in Solution

CN10034P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹⁵N

15N GB1 in Solution

CN10034P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹⁵N

13C, 15N GB1 in Solution

CCN10034P10
3 - 6 weeks

• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N GB1 in Solution

CCN10034P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N GB1 in Solution

CCN10034P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N

15N Microcrystalline GB1

CN10033P10
3 - 6 weeks

• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹⁵N

15N Microcrystalline GB1

CN10033P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹⁵N

15N Microcrystalline GB1

CN10033P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹⁵N

13C, 15N Microcrystalline GB1

CCN10033P10
3 - 6 weeks

• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Microcrystalline GB1

CCN10033P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Microcrystalline GB1

CCN10033P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D GB1 in Solution

CCND10034P10
3 - 6 weeks

• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D GB1 in Solution

CCND10034P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D GB1 in Solution

CCND10034P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline GB1

CCND10033P10
3 - 6 weeks

• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline GB1

CCND10033P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline GB1

CCND10033P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N Ubiquitin in 1.3 mm Bruker rotor

CCND100621P
3 - 6 weeks

• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D Ubiquitin in 1.3 mm Bruker rotor

CCN100621P
3 - 6 weeks

• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N Ubiquitin in 3.2 mm Bruker rotor

CCND100623P
3 - 6 weeks

• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

15N Ubiquitin in 3 mm NMR Tube

CN100613P
3 - 6 weeks

• Full Length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹⁵N
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

15N Ubiquitin in 5 mm NMR Tube

CN100615P
3 - 6 weeks

• Full Length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹⁵N
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

2-Ketobutyric Acid-4-13C

CC1400P1

$1,800.00

2 - 4 weeks

• Sodium Salt Hydrate
• 99% ¹³C
• 1 g

2-Keto-3-(Methyl-13C)-Butyric Acid-4-13C

CC1405P025
2 - 4 weeks

• Sodium Salt Hydrate
• 250 mg

2-Ketobutyric Acid-4-13C, 4-d1

CCD1400P1
2 - 4 weeks

• Sodium Salt Hydrate
• 99% ¹³C, 97% D
• Contains 5-10% CD₂H
• 1 g

2-Ketobutyric Acid-4-13C, 4,4-d2

CCD1405P1
2 - 4 weeks

• Sodium Salt Hydrate
• 99% ¹³C, 98% D
• 1 g

2-Ketobutyric Acid-4-13C, 3,3,4,4,4-d5

CCD1406P1
2 - 4 weeks

• Sodium Salt Hydrate
• 99% ¹³C, 50-70% D (CD₃), 97-98% D (CD₂)
• 1 g

2-Ketobutyric Acid-13C4, 3,3-d2

CCD1411P1
2 - 4 weeks

• Sodium Salt Hydrate
• 99% ¹³C, 98% D, 98% CP
• 1 g

2-Keto-3-Methylbutyric Acid-13C5, 3-d1

CCD1412P1
2 - 4 weeks

• Sodium Salt Hydrate
• 99% ¹³C, 98% D
• 1 g

2-Keto-3-(Methyl-d3)-Butyric Acid-4-13C

CCD1415P1
2 - 4 weeks

• Sodium Salt Hydrate
• 99% ¹³C, 98% D
• 1 g

2-Keto-3-(Methyl-d3)-Butyric Acid-1,2,3,4-13C4, 3-d1

CCD1418P1
2 - 4 weeks

• Sodium Salt Hydrate
• 99% ¹³C, 98% D
• 1 g

2-Keto-3-(Methyl-d3)-Butyric Acid-1,2,3,4-13C4

CCD1419P1
2 - 4 weeks

• Sodium Salt Hydrate
• 99% ¹³C, 98% D
• 1 g

2-Keto-3-(Methyl-13C)-Butyric Acid-4-13C, 3-d1

CCD1420P1
2 - 4 weeks

• Sodium Salt Hydrate
• 99% ¹³C, 98% D
• 1 g

2-Keto-3-(Methyl-13C,d2)-Butyric Acid-4-13C, -d2

CCD1425P1
2 - 4 weeks

• Sodium Salt Hydrate
• 98% ¹³C, 98% D
• 1 g

2-Keto-3-Methylbutyric Acid-3-d

CD1400P1
2 - 4 weeks

• Sodium Salt Hydrate
• 98% CP
• 1 g

2-Ketobutyric Acid-3,3-d2

CD1401P1

$1,690.00

2 - 4 weeks

• Sodium Salt Hydrate
• 97% CP
• 1 g

2-Keto-3-Methylbutyric Acid-13C5

CC1406P025

$980.00

2 - 4 weeks

• Sodium Salt Hydrate
• 250 mg

2-Ketobutyric Acid-4-13C, 3,3-d2

CCD1410P025

$760.00

2 - 4 weeks

• Sodium Salt Hydrate
• 99% ¹³C, 98% D
• 250 mg

2-Keto-3-(Methyl-d3)-Butyric Acid-4-13C, 3-d1

CCD1417P025

$660.00

2 - 4 weeks

• Sodium Salt Hydrate
• 97% CP
• 250 mg

13C, 15N Ubiquitin in 3 mm NMR Tube

CCN100613P
3 - 6 weeks

• Full Length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

13C, 15N Ubiquitin in 5 mm NMR Tube

CCN100615P
3 - 6 weeks

• Full Length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

13C, 15N, D Ubiquitin in 3.2 mm Bruker rotor

CCN100623P
3 - 6 weeks

• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Ubiquitin in 3 mm NMR Tube

CCND100613P
3 - 6 weeks

• Full Length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

13C, 15N, D Ubiquitin in 5 mm NMR Tube

CCND100615P
3 - 6 weeks

• Full Length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

13C, 15N SH3 in 1.3mm Bruker rotor

CCN100521P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D SH3 in 1.3mm Bruker rotor

CCND100521P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N SH3 in 3.2mm Bruker rotor

CCN100523P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D SH3 in 3.2mm Bruker rotor

CCND100523P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

15N GB1 in 3 mm NMR Tube

CN100313P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹⁵N
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

15N GB1 in 5 mm NMR Tube

CN100315P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹⁵N
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

15N SH3 in 3mm NMR Tube

CN100513P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹⁵N
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0
• Stable for more than 2 years at 4°C

15N SH3 in 5mm NMR Tube

CN100515P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹⁵N
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0
• Stable for more than 2 years at 4°C

13C, 15N GB1 in 3 mm NMR Tube

CCN100313P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

13C, 15N GB1 in 5 mm NMR Tube

CCN100315P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

• Maltose Binding Protein (Recombinant MBP)
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Protein conc.: 1 mM
• Labeling: ¹³C, ¹⁵N
• 20 mM Phosphate, pH: 7.2, Maltotriose: 3 mM, NaN₃: 3 mM, Pefabloc: 50 µM

13C, 15N MBP in 5 mm NMR Tube

CCN100415P
3 - 6 weeks

• Maltose Binding Protein (Recombinant MBP)
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Protein conc.: 1 mM
• Labeling: ¹³C, ¹⁵N
• 20 mM Phosphate, pH: 7.2, Maltotriose: 3 mM, NaN₃: 3 mM, Pefabloc: 50 µM

13C, 15N SH3 in 3mm NMR Tube

CCN100513P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 k Da
• Labeling: ¹³C, ¹⁵N
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0
• Stable for more than 2 years at 4°C

13C, 15N SH3 in 5mm NMR Tube

CCN100515P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0
• Stable for more than 2 years at 4°C

13C, 15N, D GB1 in 3 mm NMR Tube

CCND100313P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

13C, 15N, D GB1 in 5 mm NMR Tube

CCND100315P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

15N MBP in 3 mm NMR Tube

CN100413P
3 - 6 weeks

• Maltose Binding Protein (Recombinant MBP)
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Protein conc.: 1 mM
• Labeling: ¹⁵N
• 20 mM Phosphate, pH: 7.2, Maltotriose: 3 mM, NaN₃: 3 mM, Pefabloc: 50 µM

15N MBP in 5 mm NMR Tube

CN100415P
3 - 6 weeks

• Maltose Binding Protein (Recombinant MBP)
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Protein conc.: 1 mM
• Labeling: ¹⁵N
• 20 mM Phosphate, pH: 7.2, Maltotriose: 3 mM, NaN₃: 3 mM, Pefabloc: 50 µM

13C, 15N, D SH3 in 3mm NMR Tube

CCND100513P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0
• Stable for more than 2 years at 4°C

13C, 15N, D SH3 in 5mm NMR Tube

CCND100515P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0
• Stable for more than 2 years at 4°C

13C, 15N, D MBP in 3 mm NMR Tube

CCND100413P
3 - 6 weeks

• Maltose Binding Protein (Recombinant MBP)
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Protein conc.: 1 mM
• Labeling: ¹³C, ¹⁵N, D
• 20 mM Phosphate, pH: 7.2, Maltotriose: 3 mM, NaN₃: 3 mM, Pefabloc: 50 µM

13C, 15N, D MBP in 5 mm NMR Tube

CCND100415P
3 - 6 weeks

• Maltose Binding Protein (Recombinant MBP)
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Protein conc.: 1 mM
• Labeling: ¹³C, ¹⁵N, D
• 20 mM Phosphate, pH: 7.2, Maltotriose: 3 mM, NaN₃: 3 mM, Pefabloc: 50 µM

13C, 15N GB1 in 1.3 mm Bruker rotor

CCN100321P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D GB1 in 1.3 mm Bruker rotor

CCND100321P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N

15N Calbindin in 3 mm NMR Tube

CN100113P
3 - 6 weeks

• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded (Ca and Ln loaded also available on request)
• Protein size: 8.5 kDa
• Labeling: ¹⁵N
• Concentration: 1 mM
• H₂O/D₂O: 90/10, pH: 6.0
• Protein supplied in a 3 mm NMR tube sealed under Argon

15N Calbindin in 5 mm NMR Tube

CN100115P
3 - 6 weeks

• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded (Ca and Ln loaded also available on request)
• Protein size: 8.5 kDa
• Labeling: ¹⁵N
• Concentration: 1 mM
• H₂O/D₂O: 90/10, pH: 6.0
• Protein supplied in a 3 mm NMR tube sealed under Argon

13C, 15N GB1 in 3.2 mm Bruker rotor

CCN100323P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Calbindin in 3 mm NMR Tube

CCN100113P
3 - 6 weeks

• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded (Ca and Ln loaded also available on request)
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N
• Concentration: 1 mM
• H₂O/D₂O: 90/10, pH: 6.0
• Protein supplied in a 3 mm NMR tube sealed under Argon

13C, 15N Calbindin in 5 mm NMR Tube

CCN100115P
3 - 6 weeks

• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded (Ca and Ln loaded also available on request)
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N
• Concentration: 1 mM
• H₂O/D₂O: 90/10, pH: 6.0
• Protein supplied in a 3 mm NMR tube sealed under Argon

13C, 15N, D Calbindin in 3 mm NMR Tube

CCND100113P
3 - 6 weeks

• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded (Ca and Ln loaded also available on request)
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D
• Concentration: 1 mM
• H₂O/D₂O: 90/10, pH: 6.0
• Protein supplied in a 3 mm NMR tube sealed under Argon

13C, 15N, D Calbindin in 5 mm NMR Tube

CCND100115P
3 - 6 weeks

• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded (Ca and Ln loaded also available on request)
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D
• Concentration: 1 mM
• H₂O/D₂O: 90/10, pH: 6.0
• Protein supplied in a 3 mm NMR tube sealed under Argon

13C, 15N, D GB1 in 3.2 mm Bruker rotor

CCND100323P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

L-Isoleucine-13CH3,D7

CCD4012P001
2 - 4 weeks

10 mg

L-Leucine-δ2-13CH3,D7

CCD4020P001
2 - 4 weeks

10 mg

L-Leucine-δ1-13CH3,D7

CCD4021P001
2 - 4 weeks

10 mg

L-Phenylalanine-ζ-13CH,D7

CCD4027P001
2 - 4 weeks

10 mg

L-Phenylalanine-ε-13CH,D6

CCD4029P001
2 - 4 weeks

10 mg

L-Tyrosine-ε-13CH,D5

CCD4038P001
2 - 4 weeks

10 mg

L-Valine-γ1-13CH3,D5

CCD4043P001
2 - 4 weeks

10 mg

L-Valine-γ2-13CH3,D5

CCD4044P001
2 - 4 weeks

10 mg

L-Alanine-β-13C,α-D,15N

CCDN4002P001
2 - 4 weeks

10 mg

L-Isoleucine-γ2,δ-(13CH3)2,D4,15N

CCDN4013P001
2 - 4 weeks

10 mg

L-Isoleucine-δ-13CH3,D7,15N

CCDN4014P001
2 - 4 weeks

10 mg

L-Isoleucine-γ-13CH3,D7,15N

CCDN4015P001
2 - 4 weeks

10 mg

L-Leucine-δ2-13CH3,D7,15N

CCDN4018P001
2 - 4 weeks

10 mg

L-Leucine-δ1-13CH3,D7,15N

CCDN4019P001
2 - 4 weeks

10 mg

L-Methionine-ε-13CH3,D5,15N

CCDN4025P001
2 - 4 weeks

10 mg

L-Phenylalanine-ζ-13CH,D7,15N

CCDN4028P001
2 - 4 weeks

10 mg

L-Phenylalanine-ε-13CH,D6,15N

CCDN4030P001
2 - 4 weeks

10 mg

L-Tyrosine-ε-13CH,D5,15N

CCDN4037P001
2 - 4 weeks

10 mg

L-Valine-γ1-13CH3,D5,15N

CCDN4041P001
2 - 4 weeks

10 mg

L-Valine-γ2-13CH3,D5,15N

CCDN4042P001
2 - 4 weeks

10 mg

L-Alanine-3-13C, 2-d

CCD45P1
2 - 4 weeks

¹³CH₃CD(NH₂)CO₂H

Benzaldehyde-a-13C,a-d1

CCD471P
2 - 4 weeks

CAS number: 155638-70-3
C₆H₅¹³CDO

Benzaldehyde-a-13C,d6

CCD472P
2 - 4 weeks

C₆D₅¹³CDO

L-Alanine-3-13C, 3,3,3-d3

CCD47P
2 - 4 weeks

CAS number: 285978-08-7
¹³CD₃CH(NH₂)CO₂H

L-Alanine-3-13C, 2,3,3-d3

CCD48P
2 - 4 weeks

¹³CD₂HCD(NH₂)CO₂H

2-Bromoethanol-13C2,1,1,2,2-d4

CCD490P
2 - 4 weeks

Br¹³CD₂¹³CD₂OH

L-Alanine-13C3-d4

CCD60P
2 - 4 weeks

CAS number: 100108-77-8
¹³CD₃¹³CD(NH₂)¹³CO₂H

Acrylamide-13C3,2,3,3-d3

CCD610P
2 - 4 weeks

CAS number: 287399-26-2
¹³C₃D₃H₂NO

Acetaldehyde-13C2,-d3

CCD6120P
2 - 4 weeks

¹³CD₃¹³CHO

Acetone-2-13C,-d6

CCD6203P
2 - 4 weeks

CAS number: 32479-94-0
CD₃¹³COCD₃

1-Methylxanthine-Methyl-13C,d3

CCD6350P
2 - 4 weeks

CAS number: 1202865-49-3
¹³CC₅D₃H₃N₄O₂

Cetyltrimethylammonium bromide alpha-d2 (CTAB, alpha-d2)

CD1196P
4 - 8 weeks

• CTAB α-d2
• Deuteration: 98 %
• Chemical purity > 99 %

Lauryl N,N-dimethylamine N-oxide-d31 (LDAO-d31)

CD5000P025

$2,300.00

4 - 8 weeks

• LDAO, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical Purity > 99 %

1,2-dihexanoyl-d22-sn-glycero-3-phosphocholine (6:0 D6PC-d22)

CD5010P025

$1,520.00

4 - 8 weeks

• D6PC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-diheptanoyl-d26-sn-glycero-3-phosphocholine (7:0 D7PC-d26)

CD5011P025

$1,520.00

4 - 8 weeks

• D7PC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dimyristoyl-d54-sn-glycero-3-phosphocholine (14:0 DMPC-d54)

CD5012P025

$1,140.00

4 - 8 weeks

• DMPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1-myristoyl-d27-2-myristoyl-sn-glycero-3-phosphocholine (14:0-d27-14:0 DMPC)

CD5013P
4 - 8 weeks

• DMPC, Deuterated on 1' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %

1-myristoyl-2-myristoyl-d27-sn-glycero-3-phosphocholine (14:0-14:0-d27 DMPC)

CD5014P
4 - 8 weeks

• DMPC, Deuterated on 2' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dimyristoyl-sn-glycero-3-phosphocholine-d72 (14:0 DMPC-d72)

CD5015P
4 - 8 weeks

• DMPC, Perdeuterated

1,2-dipalmitoyl-d62-sn-glycero-3-phosphocholine (16:0 DPPC-d62)

CD5016P025

$1,140.00

4 - 8 weeks

• DPPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dihexanoyl-d22-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 (6:0 D6PC-d22,d9)

CD5017P025

$3,800.00

4 - 8 weeks

• D6PC, Deuterated on both acyl chains & choline methyls
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-diheptanoyl-d26-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 (7:0 D7PC-d26,d9)

CD5018P025

$3,800.00

4 - 8 weeks

• D7PC, Deuterated on both acyl chains & choline methyls
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dimyristoyl-d54-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 (14:0 DMPC-d54,d9)

CD5019P025

$3,800.00

4 - 8 weeks

• DMPC, Deuterated on both acyl chains & choline methyls
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dihexanoyl-d22-sn-glycero-3-phosphoglycerol (6:0 D6PG-d22)

CD5020P025

$2,860.00

4 - 8 weeks

• D6PG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-diheptanoyl-d26-sn-glycero-3-phosphoglycerol, (7:0 D7PG-d26)

CD5021P025

$2,860.00

4 - 8 weeks

• D7PG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dimyristoyl-d54-sn-glycero-3-phosphoglycerol (14:0 DMPG-d54)

CD5022P025

$2,860.00

4 - 8 weeks

• DMPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dipalmitoyl-d62-sn-glycero-3-phosphoglycerol (16:0 DPPG-d62)

CD5023P025

$2,860.00

4 - 8 weeks

• DPPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %
• 100mg

1,2-dipalmitoyl-d62-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 (16:0 DPPC-d62,d9)

CD5024P025

$3,800.00

4 - 8 weeks

• DPPC, Deuterated on both acyl chains & choline methyls
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1-palmitoyl-d31-2-palmitoyl-sn-glycero-3-phosphocholine (16:0-d31-16:0 DPPC)

CD5025P
4 - 8 weeks

• DMPC, Deuterated on 1' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %

1-palmitoyl-2-palmitoyl-d31-sn-glycero-3-phosphocholine (16:0-16:0-d31 DPPC)

CD5026P
4 - 8 weeks

• DMPC, Deuterated on 2' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dihexanoyl-sn-glycero-3-phosphocholine-d40 (6:0 D6PC-d40)

CD5027P
4 - 8 weeks

D6PC, Perdeuterated

1,2-diheptanoyl-sn-glycero-3-phosphocholine-d44 (7:0 D7PC-d44)

CD5028P
4 - 8 weeks

• D7PC, Perdeuterated

1-lauroyl-2-hydroxy-d23-sn-glycero-3-phosphoglycerol (12:0 LLPG-d23)

CD5030P025

$3,800.00

4 - 8 weeks

• LLPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-myristoyl-2-hydroxy-d27-sn-glycero-3-phosphoglycerol (14:0 LMPG-d27)

CD5031P025

$3,800.00

4 - 8 weeks

• LMPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-palmitoyl-2-hydroxy-d31-sn-glycero-3-phosphoglycerol (16:0 LPPG-d31)

CD5032P025

$3,800.00

4 - 8 weeks

• LPPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-myristoyl-2-hydroxy-d27-sn-glycero-3-phosphocholine (14:0 LMPC-d27)

CD5036P025

$2,860.00

4 - 8 weeks

• LMPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-palmitoyl-2-hydroxy-d31-sn-glycero-3-phosphocholine, (16:0 LPPC-d31)

CD5037P025

$2,860.00

4 - 8 weeks

• LPPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

n-decylphosphocholine-d34 (Fos-Choline-10-d34)

CD5040P025

$2,860.00

4 - 8 weeks

• Fos-Choline-10-d34, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

n-tetradecylphosphocholine-d42 (Fos-Choline-14-d42)

CD5041P025

$2,860.00

4 - 8 weeks

• Fos-Choline-14-d42, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

4 - 8 weeks

• D6PE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-diheptanoyl-d26-sn-glycero-3-phosphoethanolamine, (7:0 D7PE-d26)

CD5062P025

$2,860.00

4 - 8 weeks

• D7PE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dimyristoyl-d54-sn-glycero-3-phosphoethanolamine (14:0 DMPE-d54)

CD5063P025

$2,860.00

4 - 8 weeks

• DMPE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %